Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362602495> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4362602495 endingPage "410" @default.
- W4362602495 startingPage "401" @default.
- W4362602495 abstract "Introduction:: Effective T-cell-mediated immunity has emerged as an essential component of human immunodeficiency virus-1 (HIV-1) vaccination. Thus, inducing an immune response against HIV proteins such as Nef and Vif, two major accessory proteins with critical roles in HIV pathogenesis and immune evasion, may lead to an effective approach. Aim: Our goal is to evaluate and compare Montanide ISA-720 and heat shock protein 27 in increasing immunostimulatory properties of HIV-1 Nef-Vif fusion protein as a vaccine candidate. Methods: In this study, the nef-vif fusion gene with and without the heat shock protein 27 (hsp27) gene was cloned in the prokaryotic pET24a (+) vector. Then, the recombinant Nef-Vif and Hsp27-Nef- Vif proteins were generated in the E. coli system. Finally, their immunostimulatory properties were evaluated in mice. Indeed, the potency of Hsp27 as an endogenous natural adjuvant was investigated to enhance HIV-1 Nef-Vif antigen-specific immunity compared to Montanide ISA-720 as a commercial adjuvant in protein-based immunization strategy. Results: Our results approved the role of Hsp27 as an effective adjuvant in the stimulation of B- and T-cell immunity. The linkage of Hsp27 to antigen could elicit higher levels of IgG1, IgG2a, IFN-γ, IL- 5 and Granzyme B than antigen mixed with Montanide ISA-720. Moreover, the ratios of IFN-γ/IL-5 and IgG2a/IgG1 were significantly increased in groups receiving Nef-Vif protein + Montanide ISA- 720 and Hsp27-Nef-Vif protein indicating the direction of the immune response pathway toward strong Th1 response. These ratios were higher in the group receiving Hsp27-Nef-Vif protein than in the group receiving Nef-Vif protein + Montanide ISA-720. Conclusion: Our findings suggest that Hsp27 can be used as an effective adjuvant to enhance antigenspecific immune responses in HIV-1 infectious models for therapeutic vaccine development." @default.
- W4362602495 created "2023-04-06" @default.
- W4362602495 creator A5018020653 @default.
- W4362602495 creator A5032662657 @default.
- W4362602495 creator A5035669571 @default.
- W4362602495 creator A5051405781 @default.
- W4362602495 creator A5066065160 @default.
- W4362602495 date "2023-06-26" @default.
- W4362602495 modified "2023-09-29" @default.
- W4362602495 title "Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct" @default.
- W4362602495 doi "https://doi.org/10.2174/0929866530666230403093538" @default.
- W4362602495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37016523" @default.
- W4362602495 hasPublicationYear "2023" @default.
- W4362602495 type Work @default.
- W4362602495 citedByCount "0" @default.
- W4362602495 crossrefType "journal-article" @default.
- W4362602495 hasAuthorship W4362602495A5018020653 @default.
- W4362602495 hasAuthorship W4362602495A5032662657 @default.
- W4362602495 hasAuthorship W4362602495A5035669571 @default.
- W4362602495 hasAuthorship W4362602495A5051405781 @default.
- W4362602495 hasAuthorship W4362602495A5066065160 @default.
- W4362602495 hasConcept C104317684 @default.
- W4362602495 hasConcept C123894998 @default.
- W4362602495 hasConcept C147483822 @default.
- W4362602495 hasConcept C159047783 @default.
- W4362602495 hasConcept C203014093 @default.
- W4362602495 hasConcept C205260736 @default.
- W4362602495 hasConcept C22070199 @default.
- W4362602495 hasConcept C2777863537 @default.
- W4362602495 hasConcept C2778190748 @default.
- W4362602495 hasConcept C2779341262 @default.
- W4362602495 hasConcept C2780195530 @default.
- W4362602495 hasConcept C40767141 @default.
- W4362602495 hasConcept C54355233 @default.
- W4362602495 hasConcept C86803240 @default.
- W4362602495 hasConcept C8891405 @default.
- W4362602495 hasConceptScore W4362602495C104317684 @default.
- W4362602495 hasConceptScore W4362602495C123894998 @default.
- W4362602495 hasConceptScore W4362602495C147483822 @default.
- W4362602495 hasConceptScore W4362602495C159047783 @default.
- W4362602495 hasConceptScore W4362602495C203014093 @default.
- W4362602495 hasConceptScore W4362602495C205260736 @default.
- W4362602495 hasConceptScore W4362602495C22070199 @default.
- W4362602495 hasConceptScore W4362602495C2777863537 @default.
- W4362602495 hasConceptScore W4362602495C2778190748 @default.
- W4362602495 hasConceptScore W4362602495C2779341262 @default.
- W4362602495 hasConceptScore W4362602495C2780195530 @default.
- W4362602495 hasConceptScore W4362602495C40767141 @default.
- W4362602495 hasConceptScore W4362602495C54355233 @default.
- W4362602495 hasConceptScore W4362602495C86803240 @default.
- W4362602495 hasConceptScore W4362602495C8891405 @default.
- W4362602495 hasIssue "5" @default.
- W4362602495 hasLocation W43626024951 @default.
- W4362602495 hasLocation W43626024952 @default.
- W4362602495 hasOpenAccess W4362602495 @default.
- W4362602495 hasPrimaryLocation W43626024951 @default.
- W4362602495 hasRelatedWork W1481917790 @default.
- W4362602495 hasRelatedWork W1976102012 @default.
- W4362602495 hasRelatedWork W2034807705 @default.
- W4362602495 hasRelatedWork W2090324576 @default.
- W4362602495 hasRelatedWork W2093242067 @default.
- W4362602495 hasRelatedWork W2200295633 @default.
- W4362602495 hasRelatedWork W2220102944 @default.
- W4362602495 hasRelatedWork W2388431301 @default.
- W4362602495 hasRelatedWork W3109192410 @default.
- W4362602495 hasRelatedWork W276659083 @default.
- W4362602495 hasVolume "30" @default.
- W4362602495 isParatext "false" @default.
- W4362602495 isRetracted "false" @default.
- W4362602495 workType "article" @default.